November 12th 2024
A 12-week regimen showed significant reductions in wrinkle severity and pigment improvement.
Expert Illustrations & Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)
View More
Cancer Summaries and Commentaries™: Clinical Updates in Melanoma from Philadelphia
View More
Dermalorian™ Webinar Series on Moderate to Severe Atopic Dermatitis
November 21, 2024 - December 5, 2024
View More
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis
View More
Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making
View More
Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis
View More
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
Comprehensive aesthetic consult boosts opportunity for positive outcomes
March 1st 2014Several factors play intertwining roles in achieving a successful aesthetic consult. Actively engaging and connecting with the patient and finding out the patient’s real reasons for wanting to look more youthful are essential for improved aesthetic outcomes, according to an expert.
ATX-101 studies yield favorable findings for reducing submental fat
February 1st 2014Top-line results from North American phase 3 clinical trials show that a series of injections with ATX-101 is safe, well-tolerated, and results in clinically meaningful and statistically significant reductions in submental fat or “double chin.”
PODCAST: A plethora of aesthetic products
February 1st 2014Cosmetic concerns are important to many of our patients. Among the difficulties faced by consumers is the blitz of advertising of new and presumably revolutionary products that can rejuvenate and preserve the youthful appearance of the skin. Many products make what sound like medical claims about the efficacy of these agents. Norman Levine, M.D., asked Zoe Draelos, M.D., the foremost authority on this subject, to discuss these issues with us.
Thicker, creamier sunscreens may trigger acne-like problems
January 1st 2014Most patients that complain of acne within 48 hours of applying sunscreen probably are not experiencing true acne with follicular rupture, but rather irritant follicular contact dermatitis or possibly miliaria rubra and miliaria pustulosa. It may be worthwhile to suggest patients try a spray formulation.